glp-1 and tamoxifen Receptor Agonists in Breast Cancer: A New Frontier in Obesity Prognosis Management Highlighting 3 ongoing clinical trials

Glucagon-like peptide-1 or GLP-1 antagonists are, however, a class of medications that mainly manage blood sugar levels in people with Type 2 diabetes

Last Updated: 09/09 Januvia, sitagliptin, patient information sheet (in plain English) Detailed Info on Signs, Symptoms, Causes, Treatments of Diabetes The information in this monograph is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects

Download our Noom Weight and Noom DPP sell sheets to learn more about adding these offerings to your health plan

Employer-sponsored plans have been expanding coverage approximately 45% of large employers now include at least one GLP-1 on their formulary for obesity treatment, up from about 25% in 2023

This suggests that semaglutide could potentially accelerate metabolism, reduce weight gain, and improve insulin sensitivity, all of which help with weight loss

You could also take a metabolic panel blood test to find other reasons why your metabolism is slow.